MLKL and FADD Are Critical for Suppressing Progressive Lymphoproliferative Disease and Activating the NLRP3 Inflammasome

MLKL, a key component downstream of RIPK3, is suggested to be a terminal executor of necroptosis. Genetic studies have revealed that Ripk3 ablation rescues embryonic lethality in Fadd- or Caspase-8-deficient mice. Given that RIPK3 has also been implicated in non-necroptotic pathways including apopto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep
Main Authors: Zhang, Xixi, Fan, Cunxian, Zhang, Haiwei, Zhao, Qun, Liu, Yongbo, Xu, Chengxian, Xie, Qun, Wu, Xiaoxia, Yu, Xianjun, Zhang, Jianke, Zhang, Haibing
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7191534/
https://ncbi.nlm.nih.gov/pubmed/27498868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2016.06.103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados